$0.4700
-0.09-16.07%
At close: -
$0.4800
0.012.14%
After Hours: Dec 12, 8:00 AM EDT
Telesis Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Telesis Bio using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-7.03 | $-4.03 | -74.4 % |
Mar 2024 | 2024-05-09 | $-5.52 | $-4.14 | -33.3 % |
Dec 2023 | 2024-03-28 | $-4.14 | $-3.96 | -4.55 % |
Sep 2023 | 2023-11-13 | $-6.66 | $-5.40 | -23.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $1.55M | $6.50M | -76.1 % |
Mar 2024 | 2024-05-09 | $3.44M | $6.90M | -50.1 % |
Dec 2023 | 2024-03-28 | $6.98M | $7.00M | -0.33 % |
Sep 2023 | 2023-11-13 | $5.56M | $7.40M | -24.8 % |
Telesis Bio (TBIO) is scheduled to report earnings on January 3, 2025. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-7.03, which missed the estimate of $-4.03.
The Actual Revenue was $1.6M, which missed the estimate of $6.5M.
Browse earnings estimates, EPS, and revenue on all stocks.